InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,294.44
(
-0.02%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.74
(
-0.20%
)
Bitcoin
63,303.16
(
-0.50%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 112

Friday, 04/20/2018 10:58:12 AM

Friday, April 20, 2018 10:58:12 AM

Post# of 438
JNP is a rarity among small cap pharmas in that they are cash flow positive.

grew revs by 24% in 2017

licensed its only approved drug to Merck and Allergan for upfronts and 10% royalties.

Pharma Services Division provides specialty engineering , trial manufacturing, consulting and incubating space to small pharma. This division grew revs by 32% from 2016.

owns 2 drug delivery platforms:
* bio-adhesive delivery system
* intravaginal ring (IVR)


developing 3 IVR drugs in the pipeline for out-licensing
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up